Stojan Z Peric': Influence Statistics

Stojan Z Peric'

Stojan Z Peric'

University of Belgrade, Faculty of Medicine, Dr Subotic Street 8, 11000, Belgrade, Serbia | University Clinical Center of Serbia, Neurology Clinic, Dr Subotic Street 6, 11000, ...

Stojan Z Peric': Expert Impact

Concepts for which Stojan Z Peric' has direct influence: Myotonic dystrophy type , Myasthenia gravis , Chronic inflammatory , Myotonic dystrophy , Dm2 patients , Variant repeats , Life qol .

Stojan Z Peric': KOL impact

Concepts related to the work of other authors for which for which Stojan Z Peric' has influence: Myasthenia gravis , Myotonic dystrophy type , Pompe disease , Chronic inflammatory , Dm1 patients , Neuromuscular junction , Acetylcholine receptor .

KOL Resume for Stojan Z Peric'

Year
2022

University of Belgrade, Faculty of Medicine, Dr Subotic Street 8, 11000, Belgrade, Serbia

2021

Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

University of Belgrade, School of Medicine, Belgrade, Serbia

2020

Faculty of Medicine, University of Belgrade, Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia

2019

Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.

2018

Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia

2017

Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Dr Subotica 6-8, 11000, Belgrade, Serbia

2016

a Neurology Clinic, Clinical Centre of Serbia and.

2015

University of Belgrade, Faculty of Medicine, Clinical Center of Serbia, Neurology Clinic, Belgrade, Serbia

2014

Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, Belgrade

2013

Serbia, Clinic of Neurology, Clinical Center of Serbia, Serbia

2012

Neurology Clinic, Faculty of Medicine, Clinical Centre of Serbia, University of Belgrade, Dr Subotica 6, 11000, Belgrade, Serbia

2011

School of Medicine, Clinical Center of Serbia, Institute of Neurology, Belgrade

2010

Institute of Neurology, Clinical Center of Serbia, School of Medicine, University of Belgrade, 6, Dr Subotica Street, 11000 Belgrade, Serbia

2009

Institute of Neurology, Clinical Center of Serbia, Belgrade, Serbia

Prominent publications by Stojan Z Peric'

KOL-Index: 14089 . Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic disease which can lead to many functional impairments, and like most other chronic disorders it might significantly affect quality of life (QoL). Information about QoL in patients with CIDP from developing countries is still lacking. We, therefore, sought to complete these data mosaic by investigating QoL in ...
Known for Chronic Inflammatory | Patients Cidp | Life Qol | Physical Domains
KOL-Index: 9468 . Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK antibodies) presents a serious gap in MG diagnosis and understanding. Recently, autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have been identified in several dSN-MG sera, but with dramatic frequency variation (∼2-50%). We have developed a cell based assay (CBA) based on ...
Known for Myasthenia Gravis | Lrp4 Antibodies | Positive Patients | Hek293 Cells
KOL-Index: 9116 . Myotonic dystrophy type 1 (DM1) is caused by a highly unstable expansion of CTG repeats in the DMPK gene. Its huge phenotypic variability cannot be explained solely by the repeat number. Recently, variant repeats within the DMPK expansions have emerged as potential disease modifiers. The frequency of variant expanded alleles was estimated in 242 DM1 patients from 174 Serbian families using ...
Known for Variant Repeats | Dmpk Expansions | Myotonic Dystrophy Type | Atypical Symptoms
KOL-Index: 8886 . CTG expansions in DMPK gene, causing myotonic dystrophy type 1 (DM1), are characterized by pronounced somatic instability. A large proportion of variability of somatic instability is explained by expansion size and patient's age at sampling, while individual-specific differences are attributed to additional factors. The age at onset is extremely variable in DM1, and inversely correlates ...
Known for Repeat Interruptions | Myotonic Dystrophy Type | Age Onset | Somatic Instability
KOL-Index: 8696 . AIM: To analyze quality of life (QoL) in a large cohort of myotonic dystrophy type 2 (DM2) patients in comparison to DM1 control group using both generic and disease specific questionnaires. In addition, we intended to identify different factors that might affect QoL of DM2 subjects. PATIENTS AND METHOD: 49 DM2 patients were compared with 42 adult-onset DM1 patients. Patients completed ...
Known for Myotonic Dystrophy Type | Dm2 Patients | Life Qol | Muscle Strength
KOL-Index: 8141 . To date, generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Although these measures are very useful, they are not usually precise enough to measure all specific characteristics of the disease. Our aim was to investigate QoL using the neuromuscular disease-specific questionnaire ...
Known for Chronic Inflammatory | Patients Cidp | Life Qol | Disability Score
KOL-Index: 8097 . Amyotrophic lateral sclerosis (ALS) is characterized by weakness, fatigue, loss of balance and coordination. The purpose of the study was to examine gait in ALS patients. Gait was compared in ALS with spinal and bulbar onset, while performing dual mental and motor tasks. Dual-task walking was performed by 27 ALS patients, 13 with spinal- and 14 with bulbar-onset disease. Twenty-nine ...
Known for Amyotrophic Lateral Sclerosis | Task Walking | Gait Pattern | Postural Instability
KOL-Index: 7784 . BACKGROUND: There is an unmet need for treatment options for generalised myasthenia gravis that are effective, targeted, well tolerated, and can be used in a broad population of patients. We aimed to assess the safety and efficacy of efgartigimod (ARGX-113), a human IgG1 antibody Fc fragment engineered to reduce pathogenic IgG autoantibody levels, in patients with generalised myasthenia ...
Known for Myasthenia Gravis | Monoclonal Antibodies | Receptor Antibody | Humans Immunoglobulin
KOL-Index: 7407 . OBJECTIVE: To investigate grey (GM) and white matter (WM) abnormalities and their effects on cognitive and behavioral deficits in a large, phenotypically and genotypically well-characterized cohort of classic adult (aDM1, age at onset ≥ 20 years) or juvenile (jDM1, age at onset <20 years) patients with myotonic dystrophy type 1 (DM1). METHODS: A case-control study including 51 DM1 patients ...
Known for Cognitive Impairment | Myotonic Dystrophy | Dm1 Patients | Type 1
KOL-Index: 7251 . Myasthenia gravis (MG) is an autoimmune disease caused by antibodies targeting the neuromuscular junction of skeletal muscles. Triple-seronegative MG (tSN-MG, without detectable AChR, MuSK and LRP4 antibodies), which accounts for ~10% of MG patients, presents a serious gap in MG diagnosis and complicates differential diagnosis of similar disorders. Several AChR antibody positive patients ...
Known for Titin Antibodies | Myasthenia Gravis | Neuromuscular Junction | Serological Diagnosis
KOL-Index: 7126 . OBJECTIVE: To assess an impact of cognitive and behavioral impairment on QoL in a larger cohort of patients with DM1. METHODS: Sixty six genetically confirmed DM1 patients (22 with juvenile (jDM1) and 44 with adult form (aDM1) of the disease) were recruited. Following behavioral tests were used: Hamilton scales for depression and anxiety (HamD and HamA), Daytime Sleepiness Scale (DSS), and ...
Known for Myotonic Dystrophy Type | Qol Patients | Cognitive Impairment | Quality Life
KOL-Index: 6990 . Magnetic resonance imaging (MRI) of muscles has recently become a significant diagnostic procedure in neuromuscular disorders. There is a lack of muscle MRI studies in patients with myotonic dystrophy type 1 (DM1), especially type 2 (DM2). To analyze fatty infiltration of leg muscles, using 3.0 T MRI in patients with genetically confirmed DM1 and DM2 with different disease durations. The ...
Known for Dm1 Dm2 | Resonance Imaging | Fatty Infiltration | Muscles Patients
KOL-Index: 6665 . OBJECTIVE: To evaluate cardiac autonomic control in patients with myasthenia gravis (MG) and thymoma. MATERIALS AND METHODS: The study was performed on 21 patients with MG and thymoma and the same number of matched healthy volunteers. Standard cardiovascular reflex tests according to Ewing and baroreflex sensitivity (BRS) at rest was applied. Spectral analysis of heart rate variability ...
Known for Myasthenia Gravis | Cardiac Autonomic | Hrv Rest | Patients Thymoma
KOL-Index: 6618 . OBJECTIVE: Guillain-Barre syndrome (GBS) is an acute disease of the peripheral nerves and their roots. Quality of life (QoL) in the first year after acute episode of GBS is still underresearched area. The aim of our study was to investigate QoL in GBS patients during a 6-month follow-up period. METHODS: Multicentric, prospective study included 74 adult patients with GBS (54% males). GBS ...
Known for Gbs Patients | Life Qol | Functional Disability | Barre Syndrome

Key People For Myotonic Dystrophy Type

Top KOLs in the world
#1
Charles A Thornton
myotonic dystrophy skeletal muscle gene expression
#2
Richard T III Moxley
myotonic dystrophy insulin receptor skeletal muscle
#3
Peter S Harper
myotonic dystrophy huntington disease south wales
#4
John David Brook
myotonic dystrophy human chromosome congenital heart disease
#5
Giovanni Meola
myotonic dystrophy type skeletal muscle dm1 dm2
#6
Helen G Harley
myotonic dystrophy chromosome 19 human pair

University of Belgrade, Faculty of Medicine, Dr Subotic Street 8, 11000, Belgrade, Serbia | University Clinical Center of Serbia, Neurology Clinic, Dr Subotic Street 6, 11000, Belgrade, Serbia | Faculty of Medicine, Neurology Clinic, University Clini